Unilever Explores Food Business Spin-Off via McCormick Merger, Extending Transformation Amid Valuation Concerns

What happened

Unilever is in early talks to separate its Food business—which generated €13.4 billion in 2024 turnover—and combine it with McCormick, as reported by the WSJ. This move goes beyond the previously announced Ice Cream demerger, part of Unilever's Growth Action Plan to focus on faster-growing categories like Beauty & Wellbeing and Personal Care. If completed, the remaining company would concentrate solely on beauty, personal-care, and home products, potentially aiming for higher growth but adding another layer of strategic complexity. DeepValue's report flags Unilever as a 'POTENTIAL SELL' due to a rich valuation—trading 39% above intrinsic value—and ongoing transformation risks, including the Ice Cream separation and €800 million productivity program. However, this new development could increase near-term execution uncertainty and dis-synergies, challenging management's ability to deliver promised savings without disrupting operations.

Implication

If executed, separating the Food business could allow Unilever to sharpen its focus on higher-margin beauty and personal care segments, potentially boosting long-term growth rates and aligning with its transformation goals. However, combining with McCormick adds integration challenges and may distract from the ongoing Ice Cream demerger and €800 million cost-saving initiative, heightening operational disruption and dis-synergy risks. From a valuation perspective, this move does not immediately address the stock's overvaluation—DeepValue's DCF implies a 39% premium—so tangible growth acceleration or a price correction is needed to justify current levels. Critical factors include assessing deal terms for value leakage, tracking execution timelines against the Ice Cream separation, and watching for any impact on free cash flow and margin targets. Ultimately, investors must balance the potential for a more focused portfolio against the increased likelihood of execution missteps in a company already struggling to deliver share price progress.

Thesis delta

The DeepValue thesis of 'POTENTIAL SELL' based on rich valuation and transformation risks is reinforced, as this news adds another strategic shift that could exacerbate execution uncertainty and delay value realization. If managed effectively, it might lead to a more streamlined, higher-growth portfolio, potentially shifting the thesis towards a 'HOLD' or 'BUY' upon evidence of improved metrics and valuation reset. Until clear details emerge and risks are mitigated, the thesis remains cautious, emphasizing vigilance on operating performance and cost savings delivery amidst overlapping restructurings.